|
FAM64A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93178806284777E-14 |
| Normal-vs-Stage2 |
2.30930000000296E-06 |
| Normal-vs-Stage3 |
2.11060000032681E-07 |
| Normal-vs-Stage4 |
9.66439994698476E-09 |
| Stage1-vs-Stage2 |
5.985200E-01 |
| Stage1-vs-Stage3 |
4.605800E-02 |
| Stage1-vs-Stage4 |
1.043810E-04 |
| Stage2-vs-Stage3 |
4.088100E-02 |
| Stage2-vs-Stage4 |
1.014860E-04 |
| Stage3-vs-Stage4 |
1.857650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.77783999999459E-05 |
| Normal-vs-Asian |
2.764100E-02 |
| Caucasian-vs-AfricanAmerican |
5.211800E-02 |
| Caucasian-vs-Asian |
9.544600E-01 |
| AfricanAmerican-vs-Asian |
3.697000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.30693242286861E-12 |
| Male-vs-Female |
1.575670E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.082000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.4422464878503E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63524749297039E-12 |
| Normal-vs-Age(81-100Yrs) |
2.234700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.328000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.400800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.134000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.311600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.809500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.357700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.481500E-03 |
| Normal-vs-Grade 2 |
5.48228129559902E-13 |
| Normal-vs-Grade 3 |
1.0091039115423E-11 |
| Normal-vs-Grade 4 |
8.51850000538334E-08 |
| Grade 1-vs-Grade 2 |
3.210200E-01 |
| Grade 1-vs-Grade 3 |
1.401570E-03 |
| Grade 1-vs-Grade 4 |
1.352180E-04 |
| Grade 2-vs-Grade 3 |
3.179400E-03 |
| Grade 2-vs-Grade 4 |
4.360700E-04 |
| Grade 3-vs-Grade 4 |
3.964400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.78146386531353E-12 |
| Normal-vs-ccB subtype |
5.9354965387115E-11 |
| ccA subtype-vs-ccB subtype |
5.55019999999296E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60260693604641E-12 |
| Normal-vs-N1 |
4.192400E-04 |
| N0-vs-N1 |
7.543100E-03 |
|
|
